FDA.reportPublic FDA data

Application 203306

Type
ANDA
Sponsor
NATCO PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LANSOPRAZOLELANSOPRAZOLECAPSULE, DELAYED REL PELLETS;ORAL15MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0591-2448LansoprazoleLansoprazoleActavis Pharma, Inc.ANDACurrent
16571-742LansoprazoleLansoprazoleRising Pharma Holdings, Inc.ANDACurrent
37808-448LansoprazoleLansoprazoleHEBANDACurrent
37808-448LansoprazoleLansoprazoleHEBANDACurrent
37808-448LansoprazoleLansoprazoleHEBANDACurrent
37808-448LansoprazoleLansoprazoleHEBANDACurrent
68016-756LansoprazoleLansoprazoleChain Drug Consortium, LLCANDACurrent
68016-756LansoprazoleLansoprazoleChain Drug Consortium, LLCANDACurrent
68016-756LansoprazoleLansoprazoleChain Drug Consortium, LLCANDACurrent